Showing results (181-190 of 877) with videos related to
Sort By:
Pageof 88
Acta Cytologica|November 1, 1978
Circulating mitotic cells in the newborn infant. The preparation of karyotypes without prior cell cultureG M Clement, D G Carpenter, C H CarterPest Management Science|November 10, 2004
Buffer zone and windbreak effects on spray drift deposition in a simulated wetlandRalph B Brown, Margaret H Carter, Gerald R StephensonRevue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1986
[Surveys of the epidemiological team of the French Rheumatology Society (RESFR) on the prescription of D-penicillamine in the treatment of rheumatoid polyarthritis]H Carter, J Chevallier, K Ghoussoub, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1997
Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane IgX Li, D Sandoval, L Freeberg, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|March 11, 2015
Genome-wide association mapping for stripe rust (Puccinia striiformis F. sp. tritici) in US Pacific Northwest winter wheat (Triticum aestivum L.)Y Naruoka, K A Garland-Campbell, A H CarterJournal of Public Health Medicine|March 1, 1994
The role of the teacher in child accident preventionY H Carter, M J Bannon, P W JonesProceedings of the National Academy of Sciences of the United States of America|March 1, 1972
Allergic encephalomyelitis in monkeys induced by a peptide from the A1 proteinE H Eylar, S Brostoff, J Jackson, et al.The Journal of the Royal College of General Practitioners|November 1, 1989
Measles--mumps--rubella immunization: the role of the general practitioner in achieving a high uptakeD Walker, M Roworth, H Carter, et al.Cancer Investigation|January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatmentG L Wampler, W H Carter, E D CampbellCurrent Opinion in Rheumatology|April 23, 2003
Upcoming biologic agents for the treatment of rheumatic diseasesJoseph C Shanahan, Larry W Moreland, Robert H CarterPageof 88